- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/04 - Antibacterial agents
Patent holdings for IPC class A61P 31/04
Total number of patents in this class: 12716
10-year publication summary
|
507
|
471
|
487
|
522
|
876
|
1017
|
1184
|
1293
|
1233
|
984
|
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1690 |
123 |
| Centre National de La Recherche Scientifique | 9432 |
88 |
| The Regents of the University of California | 18722 |
87 |
| Pfizer Inc. | 3325 |
62 |
| Wockhardt Limited | 248 |
60 |
| Novartis AG | 12124 |
59 |
| iNtRON Biotechnology, Inc. | 175 |
59 |
| Hoffmann-La Roche Inc. | 2937 |
55 |
| Intervet International B.V. | 1233 |
52 |
| Shionogi & Co., Ltd. | 934 |
51 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3263 |
50 |
| Merck Sharp & Dohme LLC | 3644 |
49 |
| President and Fellows of Harvard College | 5693 |
47 |
| Intervet Inc. | 836 |
47 |
| Daiichi Sankyo Company, Limited | 1836 |
46 |
| ContraFect Corporation | 94 |
46 |
| F. Hoffmann-La Roche AG | 7941 |
41 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2231 |
37 |
| Mondobiotech Laboratories AG | 311 |
37 |
| National Research Council of Canada | 1525 |
37 |
| Other owners | 11583 |